Deutsche Bank’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
DCM
ACA
DTC
OCA
CC
Deutsche Bank's DFTX Position: Q1 2026 in Review
Deutsche Bank increased its Definium Therapeutics (DFTX) stake by 3.4% in Q1 2026, buying an estimated $230K and bringing the position to 411,834 shares worth $7.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1135.
Deutsche Bank first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.
- Deutsche Bank held 411,834 shares of Definium Therapeutics worth $7.78M as of Q1 2026.
- Deutsche Bank bought 13,565 Definium Therapeutics shares in Q1 2026, an estimated $230K.
- Definium Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1135 holding.
- Deutsche Bank first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
- 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.